Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking strategy to diabetes management. These innovative therapies function by mimicking the inherent actions of GLP-1, a hormone produced by the https://sachinqyfu101215.bloggactif.com/40436911/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes